Table 1 Baseline advanced melanoma patient characteristics in NR and R groups. (loc adv: locally advanced; PFS: progression free survival).

From: Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients

 

Non-responders (NR, 8)

Responders (R, 10)

Age years: median (range)

61.5 (42–82)

68 (41–82)

Sex (M:F)

2:3

3:1

M0 (loc adv)

1 (12.5%)

2 (20%)

M1a

2 (25%)

6 (60%)

M1b

0 (0%)

2 (20%)

M1c

2 (25%)

0 (0%)

M1d

3 (37.5%)

0 (0%)

BRAF V600 mut

4 (50%)

0 (0%)

NRAS mut

1 (12.5%)

2 (20%)

Previous BRAFi + MEKi

3 (37.5%)

0 (0%)

PFS months: median (range)

1.7 (0.6–4.5)

not reached (8.7–not reached)

Back to article page